Matches in SemOpenAlex for { <https://semopenalex.org/work/W3212868907> ?p ?o ?g. }
- W3212868907 endingPage "e0260327" @default.
- W3212868907 startingPage "e0260327" @default.
- W3212868907 abstract "Breast cancer is the cancer most often diagnosed in women. MicroRNAs (MIRs) are short RNA molecules that bind mRNA resulting in their downregulation. MIR21 has been shown to be an oncomiR in most cancer types, including breast cancer. Most of the effects of miR-21 have been attributed to hsa-miR-21-5p that is transcribed from the leading strand of MIR21, but hsa-miR-21-3p (miR-21-3p), transcribed from the lagging strand, is much less studied. The aim of the study is to analyze whether expression of miR-21-3p is prognostic for breast cancer. MiR-21-3p association with survival, clinical and pathological characteristics was analyzed in a large breast cancer cohort and validated in three separate cohorts, including TCGA and METABRIC. Analytical tools were also used to infer miR-21-3p function and to identify potential target genes and functional pathways. The results showed that in the exploration cohort, high miR-21-3p levels associated with shorter survival and lymph node positivity. In the three validation cohorts, high miR-21-3p levels associated with pathological characteristics that predict worse prognosis. Specifically, in the largest validation cohort, METABRIC (n = 1174), high miR-21-3p levels associated with large tumors, a high grade, lymph node and HER2 positivity, and shorter breast-cancer-specific survival (HR = 1.38, CI 1.13–1.68). This association remained significant after adjusting for confounding factors. The genes with expression levels that correlated with miR-21-3p were enriched in particular pathways, including the epithelial-to-mesenchymal transition and proliferation. Among the most significantly downregulated targets were MAT2A and the tumor suppressive genes STARD13 and ZNF132. The results from this study emphasize that both 3p- and 5p-arms from a MIR warrant independent study. The data show that miR-21-3p overexpression in breast tumors is a marker of worse breast cancer progression and it affects genes in pathways that drive breast cancer by down-regulating tumor suppressor genes. The results suggest miR-21-3p as a potential biomarker." @default.
- W3212868907 created "2021-11-22" @default.
- W3212868907 creator A5039598517 @default.
- W3212868907 creator A5039760981 @default.
- W3212868907 creator A5041778908 @default.
- W3212868907 creator A5046305590 @default.
- W3212868907 creator A5049579554 @default.
- W3212868907 creator A5057234571 @default.
- W3212868907 creator A5070124483 @default.
- W3212868907 creator A5090475161 @default.
- W3212868907 date "2021-11-19" @default.
- W3212868907 modified "2023-10-18" @default.
- W3212868907 title "Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways" @default.
- W3212868907 cites W1168214783 @default.
- W3212868907 cites W1454791104 @default.
- W3212868907 cites W168471556 @default.
- W3212868907 cites W1972572472 @default.
- W3212868907 cites W1973491533 @default.
- W3212868907 cites W1983573091 @default.
- W3212868907 cites W1983811366 @default.
- W3212868907 cites W1986571428 @default.
- W3212868907 cites W1994216821 @default.
- W3212868907 cites W2005895632 @default.
- W3212868907 cites W2008955962 @default.
- W3212868907 cites W2021357863 @default.
- W3212868907 cites W2025801650 @default.
- W3212868907 cites W2026099579 @default.
- W3212868907 cites W2037416530 @default.
- W3212868907 cites W2046409229 @default.
- W3212868907 cites W2056087352 @default.
- W3212868907 cites W2058443035 @default.
- W3212868907 cites W2069935020 @default.
- W3212868907 cites W2073990533 @default.
- W3212868907 cites W2088717951 @default.
- W3212868907 cites W2088950284 @default.
- W3212868907 cites W2091418893 @default.
- W3212868907 cites W2094720383 @default.
- W3212868907 cites W2096989136 @default.
- W3212868907 cites W2106929712 @default.
- W3212868907 cites W2112027064 @default.
- W3212868907 cites W2129315871 @default.
- W3212868907 cites W2142221925 @default.
- W3212868907 cites W2143186560 @default.
- W3212868907 cites W2143250597 @default.
- W3212868907 cites W2147343434 @default.
- W3212868907 cites W2148630375 @default.
- W3212868907 cites W2149441684 @default.
- W3212868907 cites W2157710443 @default.
- W3212868907 cites W2267406668 @default.
- W3212868907 cites W2342019990 @default.
- W3212868907 cites W2375577403 @default.
- W3212868907 cites W2418616859 @default.
- W3212868907 cites W2461641536 @default.
- W3212868907 cites W2508350049 @default.
- W3212868907 cites W2508726590 @default.
- W3212868907 cites W2610626171 @default.
- W3212868907 cites W2619639925 @default.
- W3212868907 cites W2735928567 @default.
- W3212868907 cites W2760505083 @default.
- W3212868907 cites W2761399066 @default.
- W3212868907 cites W2774004004 @default.
- W3212868907 cites W2793966428 @default.
- W3212868907 cites W2795989238 @default.
- W3212868907 cites W2905162720 @default.
- W3212868907 cites W2905331035 @default.
- W3212868907 cites W2910505396 @default.
- W3212868907 cites W2920863604 @default.
- W3212868907 cites W2965649978 @default.
- W3212868907 cites W2969796003 @default.
- W3212868907 cites W2989832464 @default.
- W3212868907 cites W3010881000 @default.
- W3212868907 cites W3020955149 @default.
- W3212868907 cites W3032827286 @default.
- W3212868907 cites W3113103754 @default.
- W3212868907 cites W3123469366 @default.
- W3212868907 cites W3134069628 @default.
- W3212868907 cites W3140139122 @default.
- W3212868907 cites W3178119289 @default.
- W3212868907 cites W3202785106 @default.
- W3212868907 doi "https://doi.org/10.1371/journal.pone.0260327" @default.
- W3212868907 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8604322" @default.
- W3212868907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34797887" @default.
- W3212868907 hasPublicationYear "2021" @default.
- W3212868907 type Work @default.
- W3212868907 sameAs 3212868907 @default.
- W3212868907 citedByCount "14" @default.
- W3212868907 countsByYear W32128689072022 @default.
- W3212868907 countsByYear W32128689072023 @default.
- W3212868907 crossrefType "journal-article" @default.
- W3212868907 hasAuthorship W3212868907A5039598517 @default.
- W3212868907 hasAuthorship W3212868907A5039760981 @default.
- W3212868907 hasAuthorship W3212868907A5041778908 @default.
- W3212868907 hasAuthorship W3212868907A5046305590 @default.
- W3212868907 hasAuthorship W3212868907A5049579554 @default.
- W3212868907 hasAuthorship W3212868907A5057234571 @default.
- W3212868907 hasAuthorship W3212868907A5070124483 @default.
- W3212868907 hasAuthorship W3212868907A5090475161 @default.
- W3212868907 hasBestOaLocation W32128689071 @default.